Acadia Pharmaceuticals | DETTE



Debt Changement Date
Acadia Pharmaceuticals USD 0 0 2024-12
ALKERMES USD 0 366M 2024-12
Alnylam Pharmaceuticals USD 1.02B 967K 2024-12
Biogen USD 6.3B 1.9M 2024-12
BioMarin Pharmaceutical USD 596.24M 1.61M 2024-12
Bristol-Myers Squibb USD 49.65B 103M 2024-12
Corcept Therapeutics USD 0 0 2024-12
Cytokinetics USD 657.12M 1.1M 2024-12
Eisai JPY 219.1B 36.2B 2024-12
Eli Lilly USD 33.64B 2.52B 2024-12
Incyte USD 37.96M 5.81M 2024-12
J&J USD 36.63B 883M 2024-12
Moderna USD 62M 593M 2024-12
Neurocrine Biosciences USD 0 0 2024-12
Pfizer USD 64.35B 3.35B 2024-12
Prothena USD 0 0 2024-12
PTC Therapeutics USD 2.39B 389K 2024-12
Sarepta Therapeutics USD 1.14B 90.44M 2024-12
Ultragenyx Pharmaceutical USD 0 0 2024-12
Vertex Pharmaceuticals USD 112.8M 1.2M 2024-12



Acadia Pharmaceuticals DETTE - Les valeurs actuelles, des données historiques, des prévisions, des statistiques, des tableaux et le calendrier économique - Apr 2025.